SARS-CoV-2 Receptors are Expressed on Human Platelets and the Effect of Aspirin on Clinical Outcomes in COVID-19 Patients

Coronavirus disease-2019 (COVID-19) caused by SARS-CoV-2 is an ongoing viral pandemic marked by increased risk of thrombotic events. However, the role of platelets in the elevated observed thrombotic risk in COVID-19 and utility of anti-platelet agents in attenuating thrombosis is unknown. We aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahai, Aditya, Bhandari, Rohan, Koupenova, Milka, Freedman, Jane E., Godwin, Matthew, McIntyre, Thomas, Chung, Mina K., Iskandar, Jean-Pierre, Kamran, Hayaan, Hariri, Essa, Aggarwal, Anu, Kalra, Ankur, Bartholomew, John R., McCrae, Keith R., Elbadawi, Ayman, Svensson, Lars G., Kapadia, Samir, Cameron, Scott J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781327/
https://www.ncbi.nlm.nih.gov/pubmed/33398263
http://dx.doi.org/10.21203/rs.3.rs-119031/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781327/
https://www.ncbi.nlm.nih.gov/pubmed/33398263
http://dx.doi.org/10.21203/rs.3.rs-119031/v1

Ejemplares similares